All Articles Tagged With: "Alendronate"
Articles
Jaw Damage Lawsuit Against Fosamax Dismissed Weeks Before Trial
A federal judge has dismissed a lawsuit over Fosamax, saying that the plaintiff will be unable to establish at trial that the osteoporosis drug caused her to suffer debilitating jaw damage. The case had been scheduled for trial to begin on January 12, in what was to be the second of three bellwether trials [...]
Jury Deliberations Continue in First Trial of Fosamax Litigation
Although jurors have indicated that they will not be able to reach an agreement in the first Fosamax trial over whether a 71 year old woman woman suffered debilitating jaw necrosis as a side effect of the osteoporosis drug, U.S. District Judge John Keenan has ordered them to continue deliberations in hopes of reaching a [...]
Fosamax Osteonecrosis Suit Submitted to Jury After Three Week Trial
A New York jury has begun deliberations over whether the osteoporosis drug Fosamax caused a 71 year old woman to suffer debilitating osteonecrosis of the jaw, in the first of nearly 1,000 similar Fosamax suits pending against Merck to go to trial.
Fosamax Jaw Damage Trial Will Not Result in Punitive Damages
According to a pretrial order, Merck & Co. will not face the possibility of punitive damages in the first Fosamax trial scheduled to begin next month in New York. The case involves allegations that the drug maker failed to warn that their popular osteoporosis drug Fosamax increases the risk of debilitating jaw damage, known [...]
Fosamax Lawsuit Set to Begin August 11 in Federal MDL
The first in a series of Fosamax lawsuits are scheduled to begin next month in federal court over allegations that the popular osteoporosis drug causes permanent decay of the jawbone, known as osteonecrosis of the jaw.
Fosamax Side Effects May Increase Risk of Esophageal Tumors
According to an official from the FDA, Fosamax side effects may increase the risk of esophageal cancer. A number of cases have been reported involving individuals who developed esophageal tumors since the osteoporosis drug was first approved in 1995, including at least 8 deaths.
Fosamax Jaw Necrosis Risk Identified in New Study
According to new research from the University of Southern California, School of Dentistry, Fosamax side effects have been linked with the development of osteonecrosis of the jaw (ONJ), a debilitating condition where the jaw bone deteriorates and decays.
